These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36496545)

  • 1. Hypocortisolism as an unusual but treatable cause of dystonia-parkinsonism.
    Desjardins C; Mongin M; de Liège A; Degos B
    J Neurol; 2023 Apr; 270(4):2314-2316. PubMed ID: 36496545
    [No Abstract]   [Full Text] [Related]  

  • 2. X-linked dystonia ("Lubag") presenting predominantly with parkinsonism: a more benign phenotype?
    Evidente VG; Gwinn-Hardy K; Hardy J; Hernandez D; Singleton A
    Mov Disord; 2002 Jan; 17(1):200-2. PubMed ID: 11835466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare causes of dystonia parkinsonism.
    Schneider SA; Bhatia KP
    Curr Neurol Neurosci Rep; 2010 Nov; 10(6):431-9. PubMed ID: 20694531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopmental Gene-Related Dystonia-Parkinsonism with Onset in Adults: A Case with NAA15 Variant.
    Straka I; Švantnerová J; Minár M; Stanková S; Zech M
    Mov Disord; 2022 Sep; 37(9):1955-1957. PubMed ID: 35730864
    [No Abstract]   [Full Text] [Related]  

  • 5. Dystonia and parkinsonism as presenting CADASIL features: a case report.
    Spagnolo F; Pinto V; Rini AM; Passarella B
    Neurol Sci; 2021 Nov; 42(11):4781-4783. PubMed ID: 34322764
    [No Abstract]   [Full Text] [Related]  

  • 6. Sporadic rapid-onset dystonia-parkinsonism syndrome: failure of bilateral pallidal stimulation.
    Deutschländer A; Asmus F; Gasser T; Steude U; Bötzel K
    Mov Disord; 2005 Feb; 20(2):254-7. PubMed ID: 15455448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystonia in parkinsonian syndromes.
    Albanese A
    Adv Neurol; 2003; 91():351-60. PubMed ID: 12442693
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of Botulinum neurotoxin efficiency in dystonia associated with Parkinson's disease and atypical parkinsonism: a retrospective study with a self-reported improvement scale.
    Lapostolle A; Houot M; Mongin M; Degos B
    J Neurol; 2022 Nov; 269(11):6021-6028. PubMed ID: 35854137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case records of the Massachusetts General Hospital. Case 17-2010 - a 29-year-old woman with flexion of the left hand and foot and difficulty speaking.
    Tarsy D; Sweadner KJ; Song PC
    N Engl J Med; 2010 Jun; 362(23):2213-9. PubMed ID: 20558373
    [No Abstract]   [Full Text] [Related]  

  • 10. Generalized dystonia, athetosis, and parkinsonism associated with FOXG1 mutation.
    Méneret A; Mignot C; An I; Habert MO; Jacquette A; Vidailhet M; Bienvenu T; Roze E
    Mov Disord; 2012 Jan; 27(1):160-1. PubMed ID: 21953941
    [No Abstract]   [Full Text] [Related]  

  • 11. ATP1A3 mutation in the first asian case of rapid-onset dystonia-parkinsonism.
    Lee JY; Gollamudi S; Ozelius LJ; Kim JY; Jeon BS
    Mov Disord; 2007 Sep; 22(12):1808-9. PubMed ID: 17595045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystonia in atypical parkinsonian disorders.
    Marsili L; Bologna M; Kojovic M; Berardelli A; Espay AJ; Colosimo C
    Parkinsonism Relat Disord; 2019 Sep; 66():25-33. PubMed ID: 31443953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel compound heterozygous synaptojanin-1 mutation causes l-dopa-responsive dystonia-parkinsonism syndrome.
    Rauschendorf MA; Jost M; Stock F; Zimmer A; Rösler B; Rijntjes M; Piroth T; Coenen VA; Reinacher PC; Meyer PT; Frings L; Weiller C; Fischer J; Klebe S
    Mov Disord; 2017 Mar; 32(3):478-480. PubMed ID: 27869329
    [No Abstract]   [Full Text] [Related]  

  • 14. A subtle presentation of a treatable cause of predominant hemidystonia with minimal ataxia.
    Wrigley SM; O'Sullivan SS; Ryan AM
    Parkinsonism Relat Disord; 2023 Feb; 107():104909. PubMed ID: 34823986
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinsonism and dystonia: Clinical spectrum and diagnostic clues.
    Morales-Briceno H; Fung VSC; Bhatia KP; Balint B
    J Neurol Sci; 2022 Feb; 433():120016. PubMed ID: 34642024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonographic alteration of substantia nigra is related to parkinsonism-predominant course of X-linked dystonia-parkinsonism.
    Walter U; Rosales R; Rocco A; Westenberger A; Domingo A; Go CL; Brüggemann N; Klein C; Lee LV; Dressler D
    Parkinsonism Relat Disord; 2017 Apr; 37():43-49. PubMed ID: 28094105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of dystonia.
    Fuchs T; Ozelius LJ
    Semin Neurol; 2011 Nov; 31(5):441-8. PubMed ID: 22266882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subtle presentation of a treatable cause of predominant hemidystonia with minimal ataxia: Expert commentary.
    Teive HAG
    Parkinsonism Relat Disord; 2023 Feb; 107():105275. PubMed ID: 36635135
    [No Abstract]   [Full Text] [Related]  

  • 19. Molybdenum cofactor deficiency presenting with a parkinsonism-dystonia syndrome.
    Alkufri F; Harrower T; Rahman Y; Hughes E; Mundy H; Knibb JA; Moriarty J; Connor S; Samuel M
    Mov Disord; 2013 Mar; 28(3):399-401. PubMed ID: 23436702
    [No Abstract]   [Full Text] [Related]  

  • 20. L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome.
    Dulski J; Cerquera-Cleves C; Milanowski L; Kwiatek-Majkusiak J; Koziorowski D; Ross OA; Pentela-Nowicka J; Sławek J; Wszolek ZK
    Parkinsonism Relat Disord; 2022 Jul; 100():19-23. PubMed ID: 35691177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.